The use of botulinum toxin in paediatric hypertonia
Open Access
- 1 September 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Paediatrics & Child Health
- Vol. 10 (7) , 379-381
Abstract
Botulinum toxin has become an important component of standard practice in the management of children with hypertonia (spasticity or dystonia). Following intramuscular injection, the neurotoxin causes a reversible neuromuscular blockade, creating both muscle weakness and a reduction in tone. Frequent goals of botulinum toxin injection include improving motor function, promoting longitudinal muscle growth and decreasing painful muscle spasms. The neuromuscular blockade lasts for three to six months on average. The clinical effect may last longer and the safety profile is excellent. Strong evidence, including randomized trials, exists for the efficacy of botulinum toxin in the management of lower and upper extremity tone in children. Common clinical indications include spastic equinus (toe walking), hip subluxation, upper extremity spasticity associated with hemiplegia or quadriplegia, and multilevel leg muscle injections in children with spastic diplegia.Keywords
This publication has 17 references indexed in Scilit:
- Classification and Definition of Disorders Causing Hypertonia in ChildhoodPediatrics, 2003
- Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: child characteristics that predict a positive outcomeEuropean Journal of Neurology, 2001
- Outcome measurement of effectiveness of botulinum toxin type A in children with cerebral palsy: an ICIDH‐2 approachEuropean Journal of Neurology, 2001
- Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trialDevelopmental Medicine & Child Neurology, 2000
- Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsyJournal of Paediatrics and Child Health, 1999
- Botulinum Toxin A Compared with Stretching Casts in the Treatment of Spastic Equinus: A Randomised Prospective TrialJournal of Pediatric Orthopaedics, 1998
- Botulinum toxin A in the hemiplegia upper limb: a double‐blind trialDevelopmental Medicine & Child Neurology, 1997
- Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment.1997
- Properties and use of botulinum toxin and other microbial neurotoxins in medicine.1992
- Therapeutic Uses of Botulinum ToxinNew England Journal of Medicine, 1991